Sponsor Pipeline

Vaderis Therapeutics AG Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-04 NCT07743671 A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07743671 A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to… Hereditary Hemorrhagic Telangiectasia Not Yet Recruiting
Phase 1/2
NCT05406362 Assess Safety and Efficacy of VAD044 in HHT Patients Hereditary Hemorrhagic Telangiectasia (HHT) Active, Not Recruiting
Get alerts when Vaderis Therapeutics AG's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free